Cargando…

Prevalence of hepatitis B, hepatitis C and human immunodeficiency viral infections in patients with inflammatory bowel disease in north India

BACKGROUND/AIMS: Patients with inflammatory bowel disease (IBD) often require immunosuppressive therapy and blood transfusions and therefore are at a high risk of contracting infections due to hepatitis B (HBV) and hepatitis C (HCV) and human immunodeficiency virus (HIV). In the present study, we as...

Descripción completa

Detalles Bibliográficos
Autores principales:	Harsh, Parnita, Gupta, Vipin, Kedia, Saurabh, Bopanna, Sawan, Pilli, Sucharita, Surendernath, Makharia, Govind Kumar, Ahuja, Vineet
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Association for the Study of Intestinal Diseases 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5323314/ https://www.ncbi.nlm.nih.gov/pubmed/28239319 http://dx.doi.org/10.5217/ir.2017.15.1.97

Ejemplares similares

Familial aggregation of inflammatory bowel disease in patients with ulcerative colitis
por: Gupta, Akshita, et al.
Publicado: (2017)

High risk of tuberculosis during infliximab therapy despite tuberculosis screening in inflammatory bowel disease patients in India
por: Agarwal, Ashish, et al.
Publicado: (2018)

Impact of dietary beliefs and practices on patients with inflammatory bowel disease: An observational study from India
por: Tomar, Sanjeevani K, et al.
Publicado: (2017)

Low dose oral curcumin is not effective in induction of remission in mild to moderate ulcerative colitis: Results from a randomized double blind placebo controlled trial
por: Kedia, Saurabh, et al.
Publicado: (2017)

Higher education, professional occupation, and upper socioeconomic status are associated with lower adherence to medications in patients with inflammatory bowel disease
por: Tomar, Sanjeevani K, et al.
Publicado: (2019)

Left‐sided colitis and extensive colitis have similar colectomy rates after index episode of acute severe colitis: A long‐term follow‐up study
por: Jain, Saransh, et al.
Publicado: (2017)

Body Composition in Crohn's Disease and Ulcerative Colitis: Correlation with Disease Severity and Duration
por: Yadav, Dawesh P., et al.
Publicado: (2017)

Accuracy of computed tomographic features in differentiating intestinal tuberculosis from Crohn's disease: a systematic review with meta-analysis
por: Kedia, Saurabh, et al.
Publicado: (2017)

Are Truelove and Witts criteria for diagnosing acute severe colitis relevant for the Indian population? A prospective study
por: Jain, Saransh, et al.
Publicado: (2018)

Urinary potassium is a potential biomarker of disease activity in Ulcerative colitis and displays in vitro immunotolerant role
por: Goyal, Sandeep, et al.
Publicado: (2017)

Evaluation of Xpert MTB/RIF assay performance in the diagnosis of abdominal tuberculosis
por: Kumar, Suraj, et al.
Publicado: (2017)

Role of random biopsies in surveillance of dysplasia in ulcerative colitis patients with high risk of colorectal cancer
por: Bopanna, Sawan, et al.
Publicado: (2016)

Prevalence and Association of Mycobacterium avium subspecies paratuberculosis with Disease Course in Patients with Ulcero-Constrictive Ileocolonic Disease
por: Khan, Imteyaz Ahmad, et al.
Publicado: (2016)

Efficacy and tolerability of hyperbaric oxygen therapy in small bowel stricturing Crohn’s disease: a pilot study
por: Kante, Bhaskar, et al.
Publicado: (2022)

Long‐term outcomes of anti‐tumor necrosis factor therapy and surgery in nonperianal fistulizing Crohn's disease
por: Vuyyuru, Sudheer K, et al.
Publicado: (2021)

High seroprevalence against SARS-CoV-2 in non-vaccinated patients with inflammatory bowel disease from Northern India
por: Kante, Bhaskar, et al.
Publicado: (2023)

Does the road to primary prevention of inflammatory bowel disease start from childhood?
por: Kedia, Saurabh, et al.
Publicado: (2022)

Differentiating Crohn’s disease from intestinal tuberculosis
por: Kedia, Saurabh, et al.
Publicado: (2019)

Long-term Gastrointestinal Sequelae Following COVID-19: A Prospective Follow-up Cohort Study
por: Golla, Rithvik, et al.
Publicado: (2023)

Su1075: SIMILAR RISK OF INFECTION WITH SARS-COV-2 IN IMMUNOCOMPROMISED AND IMMUNOCOMPETENT PATIENTS WITH INFLAMMATORY BOWEL DISEASE AND HEALTHY CONTROLS
por: Kante, Bhaskar, et al.
Publicado: (2022)

Management of inflammatory bowel disease in older persons: evolving paradigms
por: Kedia, Saurabh, et al.
Publicado: (2018)

High mucosal cytomegalovirus DNA helps predict adverse short-term outcome in acute severe ulcerative colitis
por: Jain, Saransh, et al.
Publicado: (2021)

Site-Specific MicroRNA Expression May Lead to Different Subtypes in Ulcerative Colitis
por: Ranjha, Raju, et al.
Publicado: (2015)

Molecular Characterization and Subtyping of Blastocystis Species in Irritable Bowel Syndrome Patients from North India
por: Das, Rojaleen, et al.
Publicado: (2016)

Selective M1 macrophage polarization in granuloma-positive and granuloma-negative Crohn's disease, in comparison to intestinal tuberculosis
por: Das, Prasenjit, et al.
Publicado: (2018)

Real world analysis on the efficacy and safety of anti-tumor necrosis factor therapy in patients with stricturing Crohn’s disease
por: Vuyyuru, Sudheer K., et al.
Publicado: (2021)

Colitis and Crohn’s Foundation (India) consensus statements on use of 5-aminosalicylic acid in inflammatory bowel disease
por: Sood, Ajit, et al.
Publicado: (2020)

Addition of computed tomography chest increases the diagnosis rate in patients with suspected intestinal tuberculosis
por: Kedia, Saurabh, et al.
Publicado: (2022)

Prospective validation of CD4(+) CD25(+) FOXP3(+) T-regulatory cells as an immunological marker to differentiate intestinal tuberculosis from Crohn’s disease
por: Rampal, Ritika, et al.
Publicado: (2021)

Fecal microbiota transplantation refurbishes the crypt-associated microbiota in ulcerative colitis
por: Markandey, Manasvini, et al.
Publicado: (2023)

Development and Validation of a Smartphone Application for Telenutrition in Patients with Inflammatory Bowel Disease
por: Gupta, Arti, et al.
Publicado: (2022)

Intestinal tuberculosis or Crohn's disease: Illusion or delusion or allusion
por: Kedia, Saurabh, et al.
Publicado: (2021)

Human gut microbiome: A primer for the clinician
por: Kedia, Saurabh, et al.
Publicado: (2023)

Interferon-gamma release assay has poor diagnostic accuracy in differentiating intestinal tuberculosis from Crohn’s disease in tuberculosis endemic areas
por: Sachdeva, Karan, et al.
Publicado: (2023)

Is There True Gender Difference of Irritable Bowel Syndrome in Asia?: Author's Reply
por: Makharia, Govind K
Publicado: (2011)

An Indian national survey of therapeutic drug monitoring with anti-tumor necrosis (TNF) medications in inflammatory bowel disease
por: Patel, Rajan N., et al.
Publicado: (2020)

CD4(+) CD25(+) FOXP3(+) T cell frequency in the peripheral blood is a biomarker that distinguishes intestinal tuberculosis from Crohn’s disease
por: Tiwari, Veena, et al.
Publicado: (2018)

Efficacy and tolerability of exclusive enteral nutrition in adult patients with complicated Crohn’s disease
por: Sharma, Sanchit, et al.
Publicado: (2021)

Opportunities and challenges in the management of celiac disease in Asia
por: Agarwal, Ashish, et al.
Publicado: (2020)

Emergence of Celiac Disease and Gluten-related Disorders in Asia
por: Mohta, Srikant, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_g0hv1ht9i8sfkosf4lnomgfl8j